title: Medium-term outcome using sirolimus-tacrolimus combination in adult renal transplant recipients.
authors.affiliation: Department of Nephrology, New York Medical College, Valhalla, NY, USA.
authors.forename: I
authors.initials: I
authors.lastname: Rashid
authors.forename: R
authors.initials: R
authors.lastname: El-Sabrout
authors.forename: F
authors.initials: F
authors.lastname: Butt
authors.forename: V
authors.initials: V
authors.lastname: Delaney
authors.forename: M
authors.initials: M
authors.lastname: Qadir
authors.forename: P
authors.initials: P
authors.lastname: Hanson
authors.forename: K
authors.initials: K
authors.lastname: Butt
mesh_terms: D000328:Adult; D000368:Aged; D003920:Diabetes Mellitus / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007518:Isoantibodies / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D007518:Isoantibodies; D020123:Sirolimus; D016559:Tacrolimus